Tech Company Financing Transactions
Aprecia Pharmaceuticals Funding Round
Aprecia Pharmaceuticals secured a $38.8 million funding round on 9/1/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
9/1/2015
Transaction Type
Debt
Amount
$38,750,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10901 Kenwood Rd.
Blue Ash, OH 45242
USA
Blue Ash, OH 45242
USA
Phone
Website
Email Address
Overview
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Thomas Arington
Chief Executive Officer
Christopher Gilmore
Chief Financial Officer
Mike Rohlfs
Chief Technical Officer
Jaedeok Yoo
Vice President
Don Wetherhold
Browse more venture capital transactions:
Prev: 9/1/2015: Credo Semiconductor venture capital transaction
Next: 9/1/2015: Cozy venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs